Evidence map›Paper›PMID 35082036›Full record

ReviewPesticide biochemistry and physiology2022

New chemistries for the control of human head lice, Pediculus humanus capitis: A mini-review.

John M Clark

Open access · greenAbstract readReview
In one paragraph

Review in Pesticide biochemistry and physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

John M ClarkDepartment of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA 01002, USA. Electronic address: jclark@vasci.umass.edu.
University of Massachusetts Amherst · US

Funding

Head Louse Resistance and Control of PediculosisR01AI045062 · NIAID · UNIVERSITY OF MASSACHUSETTS AMHERST · PI CLARK, JOHN MARSHALL · 2000 to 2008
$996k
Functional and transcriptional profiling of lice defenses against pediculicidesR56AI081933 · NIAID · UNIVERSITY OF MASSACHUSETTS AMHERST · PI CLARK, JOHN MARSHALL · 2010 to 2010
$385k
NIAID NIH HHS R01 AI045062NIAID NIH HHS R56 AI081933
6 · The paper itself

Abstract

Pediculus lice represent one of the longest and most prevalent parasitic infestations of humans. Head lice are an economic and social concern whereas body lice pose a more serious public health threat. Significant progress has been made in the study of human lice over the last 10 years, allowing for new approaches in their control. An in vitro rearing system has made it possible to maintain insecticide-susceptible and -resistant reference strains, which allowed an in depth study of pediculicide resistance, including its underlying molecular mechanisms and the detection and monitoring of resistance. The generation of inbreed strains facilitated the efficient sequencing, assembly and annotation of the genomes and transcriptomes of both lice. The use of functional genomics and reverse genetics elucidated the genetics involved in the evolution of resistance and the discovery of novel target sites for the development of new pediculicides. In this review, four new effective pediculicide products, each with different mode of action and unique chemistries, will be presented. They have been found to be safe and selective, and control resistant lice. As such, they meet the criteria necessary to be used in rotations as a sustainable resistance management strategy.

Indexed as

InsecticidesLice InfestationsPediculusAnimalsHumansInsecticidesAbametapirDimethiconeHuman head liceIvermectinPediculicidesSpinosad

Identifiers

PMID35082036
PMCPMC8795694
OpenAlexW4200267209

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.